{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:18:43Z","timestamp":1762219123982,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.neurol.2025.02.004","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:27:12Z","timestamp":1741332432000},"page":"332-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysis"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6630-394X","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Leroy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Laure","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Schraen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Deramecourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Skrobala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Lecerf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Huin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Bertoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4386-6045","authenticated-orcid":false,"given":"Thibaud","family":"Lebouvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2025.02.004_bib0285","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement [Internet]"},{"key":"10.1016\/j.neurol.2025.02.004_bib0290","first-page":"161","article-title":"Frontotemporal dementia is the leading cause of \u201ctrue\u201d A\u2212\/T+ profiles defined with A\u03b242\/40 ratio","volume":"11","author":"Pouclet-Courtemanche","year":"2019","journal-title":"Alzheimers Dement Diagn Assess Dis Monit [Internet]"},{"issue":"4","key":"10.1016\/j.neurol.2025.02.004_bib0295","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","article-title":"Amyloid \u03b2 peptide ratio 42\/40 but not A\u03b242 correlates with phospho-Tau in patients with low- and high-CSF A\u03b240 load","volume":"101","author":"Wiltfang","year":"2007","journal-title":"J Neurochem [Internet]"},{"issue":"3","key":"10.1016\/j.neurol.2025.02.004_bib0300","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","article-title":"Neurochemical diagnosis of Alzheimer's dementia by CSF A\u03b242, A\u03b242\/A\u03b240 ratio and total tau","volume":"25","author":"Lewczuk","year":"2004","journal-title":"Neurobiol Aging [Internet]"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13195-015-0114-5","article-title":"Cerebrospinal fluid amyloid-\u03b2 42\/40 ratio in clinical setting of memory centers: a multicentric study","volume":"7","author":"Dumurgier","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.neurol.2025.02.004_bib0310","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnagi.2018.00138","article-title":"Relevance of A\u03b242\/40 ratio for detection of Alzheimer disease pathology in clinical routine: the PLMR Scale","volume":"10","author":"Lehmann","year":"2018","journal-title":"Front Aging Neurosci [Internet]"},{"issue":"2","key":"10.1016\/j.neurol.2025.02.004_bib0315","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-160722","article-title":"Cerebrospinal fluid A\u03b242\/40 corresponds better than A\u03b242 to amyloid PET in Alzheimer's disease. Lehmann S, editor","volume":"55","author":"Lewczuk","year":"2016","journal-title":"J Alzheimers Dis [Internet]"},{"issue":"3","key":"10.1016\/j.neurol.2025.02.004_bib0320","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/acn3.274","article-title":"CSF A \u03b2 42\/A \u03b2 40 and A \u03b2 42\/A \u03b2 38 ratios: better diagnostic markers of Alzheimer disease","volume":"3","author":"Janelidze","year":"2016","journal-title":"Ann Clin Transl Neurol [Internet]"},{"issue":"2","key":"10.1016\/j.neurol.2025.02.004_bib0325","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-170327","article-title":"The cerebrospinal fluid A\u03b21-42\/A\u03b21-40 ratio improves concordance with amyloid-PET for diagnosing Alzheimer's disease in a clinical setting","volume":"60","author":"Niemantsverdriet","year":"2017","journal-title":"J Alzheimers Dis [Internet]"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0330","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13195-015-0114-5","article-title":"Cerebrospinal fluid amyloid-\u03b2 42\/40 ratio in clinical setting of memory centers: a multicentric study","volume":"7","author":"Dumurgier","year":"2015","journal-title":"Alzheimers Res Ther [Internet]"},{"issue":"3","key":"10.1016\/j.neurol.2025.02.004_bib0335","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurol.2025.02.004_bib0340","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O\u2019Brien","year":"2011","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"10.1016\/j.neurol.2025.02.004_bib0345","first-page":"S390","article-title":"Impact of harmonization of collection tubes on Alzheimer's disease diagnosis","volume":"10","author":"Lehmann","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.neurol.2025.02.004_bib0350","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"year":"1988","series-title":"Dementia Rating Scale. Professional manual","author":"Mattis","key":"10.1016\/j.neurol.2025.02.004_bib0355"},{"issue":"7","key":"10.1016\/j.neurol.2025.02.004_bib0360","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/arclin\/acu031","article-title":"The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's disease","volume":"29","author":"Lemos","year":"2014","journal-title":"Arch Clin Neuropsychol [Internet]"},{"issue":"2","key":"10.1016\/j.neurol.2025.02.004_bib0365","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jnnp.73.2.126","article-title":"Visual association test to detect early dementia of the Alzheimer type","volume":"73","author":"Lindeboom","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry [Internet]"},{"issue":"5","key":"10.1016\/j.neurol.2025.02.004_bib0370","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1037\/h0044509","article-title":"The relation of the trail making test to organic brain damage","volume":"19","author":"Reitan","year":"1955","journal-title":"J Consult Psychol"},{"issue":"6","key":"10.1016\/j.neurol.2025.02.004_bib0375","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"Journal of Experimental Psychology"},{"year":"1991","series-title":"Visual object and space perception battery","author":"Warrington","key":"10.1016\/j.neurol.2025.02.004_bib0380"},{"issue":"2","key":"10.1016\/j.neurol.2025.02.004_bib0385","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"Am J Roentgenol [Internet]"},{"issue":"10","key":"10.1016\/j.neurol.2025.02.004_bib0390","doi-asserted-by":"crossref","first-page":"e1001684","DOI":"10.1371\/journal.pbio.1001684","article-title":"A critical role for the hippocampus in the valuation of imagined outcomes","volume":"11","author":"Lebreton","year":"2013","journal-title":"PLoS Biol [Internet]"},{"issue":"6","key":"10.1016\/j.neurol.2025.02.004_bib0395","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1006\/nimg.2000.0582","article-title":"Voxel-based morphometry\u2014The methods","volume":"11","author":"Ashburner","year":"2000","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0400","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/nimg.2001.0786","article-title":"A voxel-based morphometric study of ageing in 465 normal adult human brains","volume":"14","author":"Good","year":"2001","journal-title":"NeuroImage [Internet]"},{"key":"10.1016\/j.neurol.2025.02.004_bib0405","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"NeuroImage [Internet]"},{"key":"10.1016\/j.neurol.2025.02.004_bib0410","unstructured":"SPM\u00a0\u2013\u00a0Statistical Parametric Mapping [Internet]. [cited 2021 Apr 27. Available from: https:\/\/www.fil.ion.ucl.ac.uk\/spm\/]."},{"issue":"11","key":"10.1016\/j.neurol.2025.02.004_bib0415","article-title":"TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E","volume":"40","author":"Koch","year":"2002","journal-title":"Clin Chem Lab Med [Internet]"},{"key":"10.1016\/j.neurol.2025.02.004_bib0420","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2020.07.011","article-title":"Does amnesia specifically predict Alzheimer's pathology? A neuropathological study","volume":"95","author":"Bertoux","year":"2020","journal-title":"Neurobiol Aging [Internet]"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement [Internet]"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.neurol.2025.02.004_bib0435","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2019.07.015","article-title":"Sulcal morphology in Alzheimer's disease: an effective marker of diagnosis and cognition","volume":"84","author":"Bertoux","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2025.02.004_bib0440","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","article-title":"Combination assay of CSF Tau, Ab1-40 and Ab1-42(43) as a biochemical marker of Alzheimer's disease","volume":"7","author":"Shoji","year":"1998","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.neurol.2025.02.004_bib0445","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000100926","article-title":"Prediction of Alzheimer's disease using the CSF A\u03b242\/A\u03b240 ratio in patients with mild cognitive impairment","volume":"23","author":"Hansson","year":"2007","journal-title":"Dement Geriatr Cogn Disord [Internet]"},{"issue":"2","key":"10.1016\/j.neurol.2025.02.004_bib0450","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00702-008-0177-6","article-title":"Combined CSF tau, p-tau181 and amyloid-\u03b2 38\/40\/42 for diagnosing Alzheimer's disease","volume":"116","author":"Welge","year":"2009","journal-title":"J Neural Transm [Internet]"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0455","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13195-018-0362-2","article-title":"Addition of the A\u03b242\/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairment","volume":"10","author":"Baldeiras","year":"2018","journal-title":"Alzheimers Res Ther [Internet]"},{"issue":"5","key":"10.1016\/j.neurol.2025.02.004_bib0460","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/156720510791383796","article-title":"The cerebrospinal fluid amyloid 42\/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia","volume":"7","author":"Spies","year":"2010","journal-title":"J Curr Alzh Res"},{"issue":"3","key":"10.1016\/j.neurol.2025.02.004_bib0465","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-2011-110515","article-title":"Decreased sA\u03b2PP\u03b2, A\u03b238, and A\u03b240 cerebrospinal fluid levels in frontotemporal dementia","volume":"26","author":"Gabelle","year":"2011","journal-title":"J Alzheimers Dis [Internet]"},{"issue":"4","key":"10.1016\/j.neurol.2025.02.004_bib0470","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3233\/JAD-130107","article-title":"Cerebrospinal fluid A\u03b21-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels","volume":"36","author":"Slaets","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.neurol.2025.02.004_bib0475","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3233\/JAD-150731","article-title":"Diagnostic value of cerebrospinal fluid biomarkers (Phospho-Tau181, total-Tau, A\u03b242, and A\u03b240) in prodromal stage of Alzheimer's disease and dementia with Lewy bodies","volume":"51","author":"Bousiges","year":"2016","journal-title":"J Alzheimers Dis [Internet]"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2025.02.004_bib0480","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000353442","article-title":"Evaluation of the cerebrospinal fluid amyloid-\u03b21-42\/Amyloid-\u03b2 1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders","volume":"36","author":"Nutu","year":"2013","journal-title":"Dement Geriatr Cogn Disord [Internet]"},{"key":"10.1016\/j.neurol.2025.02.004_bib0485","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnagi.2018.00138","article-title":"Relevance of A\u03b242\/40 ratio for detection of Alzheimer disease pathology in clinical routine: the PLMR Scale","volume":"10","author":"Lehmann","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0490","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal Fluid Levels of NL-Amyloid 1-42, but not of Tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neurol.2025.02.004_bib0495","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.02.004_bib0500","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3233\/JAD-2012-121267","article-title":"Confirmation of the amyloidogenic process in posterior cortical atrophy: value of the A\u03b242\/A\u03b240 ratio","volume":"33","author":"Beaufils","year":"2013","journal-title":"J Alzheimers Dis [Internet]"},{"issue":"21","key":"10.1016\/j.neurol.2025.02.004_bib0505","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/WNL.0b013e31821ccc98","article-title":"CSF biomarkers in posterior cortical atrophy","volume":"76","author":"Seguin","year":"2011","journal-title":"Neurology [Internet]"},{"issue":"3","key":"10.1016\/j.neurol.2025.02.004_bib0510","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.2010.207183","article-title":"Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias","volume":"82","author":"de Souza","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry [Internet]"},{"issue":"2","key":"10.1016\/j.neurol.2025.02.004_bib0515","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology\u00a0\u2013\u00a0concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0520","doi-asserted-by":"crossref","first-page":"e12031","DOI":"10.1002\/dad2.12031","article-title":"Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders","volume":"13","author":"Eckerstr\u00f6m","year":"2021","journal-title":"Alzheimers Dement Amst Neth"},{"key":"10.1016\/j.neurol.2025.02.004_bib0525","article-title":"Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics [Internet]","author":"Tijms","year":"2020","journal-title":"Neurology"},{"issue":"89","key":"10.1016\/j.neurol.2025.02.004_bib0530","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.neurol.2025.02.004_bib0540","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1373\/clinchem.2011.178368","article-title":"Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosis","volume":"58","author":"Perret-Liaudet","year":"2012","journal-title":"Clin Chem [Internet]"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0560","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13195-019-0517-9","article-title":"Towards a unified protocol for handling of CSF before \u03b2-amyloid measurements","volume":"11","author":"Janelidze","year":"2019","journal-title":"Alzheimers Res Ther [Internet]"},{"issue":"3","key":"10.1016\/j.neurol.2025.02.004_bib0550","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","article-title":"Abeta40 inhibits amyloid deposition in vivo","volume":"27","author":"Kim","year":"2007","journal-title":"J Neurosci"},{"issue":"19","key":"10.1016\/j.neurol.2025.02.004_bib0555","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","article-title":"Neurotoxicity of Alzheimer's disease A\u03b2 peptides is induced by small changes in the A\u03b242 to A\u03b240 ratio","volume":"29","author":"Kuperstein","year":"2010","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.neurol.2025.02.004_bib0535","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol [Internet]"},{"issue":"12","key":"10.1016\/j.neurol.2025.02.004_bib561","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.neurol.2025.02.004_bib0545","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13195-020-00696-1","article-title":"Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals","volume":"12","author":"Lehmann","year":"2020","journal-title":"Alzheimers Res Ther [Internet]"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725004321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725004321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:14:56Z","timestamp":1762218896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725004321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0035378725004321"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.02.004","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysis","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}